PRIMECAP Odyssey Growth Fund (POGRX - Free Report) seeks capital appreciation. POGRX normally invests in common stocks of U.S. companies that possess high earnings growth. POGRX may invest in companies from different sectors and diverse market-cap.
This Large Cap Growth producthas a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 13.8% and 5 year almost 18.7%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
POGRX’s performance, as of the last filing, when compared to funds in its category was in the top 5% over the past 1 year, and in the top 3% over the past 3 years and in the top 1% over the past 5 years.
The PRIMECAP Odyssey Growth Fund, as of the last filing, allocates their fund in top two major groups; Large Growth and Large Value. Further, as of the last filing, Abiomed Inc, Seattle Genetics Inc and Eli Lilly and Co were the top holdings for POGRX.
This Zacks Rank #2 (Buy) was incepted in November 2004 and is managed by Primecap Oddys. POGRX carries an expense ratio of 0.66% and requires a minimal initial investment of $2,000.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>